penile traction does not improve outcomes with collagenase ...penile traction does not improve...
TRANSCRIPT
©2015 MFMER | slide-1
Penile Traction Does Not Improve Outcomes with Collagenase Clostridium Histolyticum for the
Treatment of Peyronie’s Disease
Matthew Ziegelmann*, Boyd Viers, Brian Montgomery, Ross Avant,
Josh Savage, Landon Trost
Mayo Clinic
Department of Urology
Rochester, MN
SMSNA Fall Scientific Meeting
November 6, 2016
Scottsdale, AZ
©2015 MFMER | slide-2
Introduction
• Penile Traction for PD
• Monotherapy
• Concurrent therapy (surgery, intralesional injections)
• Collagenase clostridium histolyticum?
©2015 MFMER | slide-3
OBJECTIVE
• Evaluate our experience and outcomes in men undergoing concurrent penile traction with CCH
• Penile curvature improvement
• SPL
• Restoration of penetrative intercourse
• Prevention of surgery
©2015 MFMER | slide-4
Methods and materials
• CCH treatment for PD between March 2014 and July 2016
• Prospectively maintained database
• CCH
• Manual modeling
• PTT – recommended 3 hrs/day
• Patient reported utilization (hours per day, days per week)
• Andropenis® (Andromedical America-Asia; New York)
• Follow-up
• Patient questionnaires (subjective outcomes)
• Repeat final (+/- interval) curve assessment
• Statistical analysis
©2015 MFMER | slide-5
Results
Series 1
120 patients
Total Cohort:
120 patients
Series 3
80 patients
Series 2
109 patients
Series 4
65 patients
Objective Follow-up:
51 patients
©2015 MFMER | slide-6
Results: baseline characteristics
PTT (N=35) No PTT (N=16) P-value
Age (years)
Mean (SD) 59 (9) 56 (67) 0.27
BMI
Mean (SD) 29 (5) 29 (55) 0.83
PD duration (mo)
Mean (SD) 24 (28) 19 (15) 0.53
Duration of curve stability (mo)
Mean (SD) 14 (24) 10 (9) 0.57
Multiplanar curve
n (%) 16 (46) 6 (38) 0.58
Indentation
n (%) 13 (37) 8 (50) 0.39
Calcification
n( %) 4 (11) 4 (25) 0.38
©2015 MFMER | slide-7
Results: baseline characteristics
PTT (N=35) No PTT (N=16) P-value
Primary Curve in
degrees,
mean (SD)
56 (19) 51 (20) 0.41
Secondary Curve in
degrees,
mean (SD)
12 (16) 11 (14) 0.92
Composite curve in
degrees,
mean (SD)
67 (25) 62 (25) 0.49
Stretched penile length
(mm)
135 (20) 138 (22) 0.77
Traction
Hrs/day,
mean (SD)
2 (1) 0 (0) --
Hrs/wk,
mean (SD)
10 (6) 0 (0) --
Hrs total,
mean (SD)
256 (173) 0 (0) --
©2015 MFMER | slide-8
©2015 MFMER | slide-9
Results: curve improvement
PTT (+) PTT (-) P-value
Absolute improvement (deg)
Primary curve, mean (SD) 16.1 (14.9) 20.8 (15.3) 0.30
Composite curve, mean (SD) 19.6 (16.1) 23.6 (19.9) 0.45
Relative improvement (%)
Primary curve, mean (SD) 30.4 (32.5) 43 (32.6)
Composite, mean (SD) 32.6 (26.8) 27.5 (30.1)
©2015 MFMER | slide-10
Results: curve improvement by traction durationTraction hours per day (p=0.63) Traction hours per week (p=0.60)
Traction hours total (p=0.81)
©2015 MFMER | slide-11
Results: SPL (corona to pubis)
0
2
4
6
8
10
12
14
Initial SPL
Final SPL
P=0.21
13.5 13.9 13.513.8
PTT (+) PTT (-)
©2015 MFMER | slide-12
Results: subjective outcomes
PTT (+) PTT (-) P-value
Restoration of
penetrative intercourse
n (%)
9 (69) 4 (57) 0.80
Prevention of surgery
n (%)
16 (55) 6 (43) 0.86
Patient-reported %
improvement in curve
mean (SD)
31.4 (31.1) 42.2 (32.3) 0.42
©2015 MFMER | slide-13
Limitations
• Single institution
• Lack of control group
• Low adherence to recommended PTT duration
• Patient report
• Andropenis
Strengths
• Analysis of objective and subjective outcomes
• Real-life data – PTT utilization in actual clinical practice
©2015 MFMER | slide-14
• Actual utilization of concurrent PTT with CCH declined in both duration and frequency with subsequent CCH series
• PTT did not significantly improve the extent of penile curve improvement realized with CCH
CONCLUSIONS
©2015 MFMER | slide-15
• While not statistically significant, there was a trend towards increased SPL in patients who perform concurrent PTT (clinical significance is questionable)
• Further prospective, randomized research is required to determine the role for concurrent PTT with CCH
CONCLUSIONS
©2015 MFMER | slide-16
THANK YOU